MS-DRG 830 — MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC
FY2026 payment factors
- Relative weight
- 1.5050
- Geometric mean LOS
- 2.10
- Arithmetic mean LOS
- 2.60
- Post-acute transfer
- No
Other DRGs in MDC 17
The with-MCC, with-CC and without-CC/MCC splits usually sit next to each other here. Those are what a documentation query is actually deciding between, and the weight gap between them is why the query is worth raising.
- 820LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC5.8648
- 821LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC2.2386
- 822LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC1.2040
- 823LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC4.5848
- 824LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC2.2656
- 825LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC1.3494
- 826MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC4.6778
- 827MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC2.3112
- 828MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC1.7038
- 829MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC3.1600
- 834ACUTE LEUKEMIA WITH MCC5.4899
- 835ACUTE LEUKEMIA WITH CC2.0858
- 836ACUTE LEUKEMIA WITHOUT CC/MCC1.2195
- 837CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC4.8043
- 838CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT2.0874
- 839CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC1.4439
- 840LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC3.2349
- 841LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC1.6314
- 842LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC1.0104
- 843OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC1.9948
- 844OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC1.2174
- 845OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC0.8516
- 846CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC2.5925
- 847CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC1.3082
- 848CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC0.8494
- 849RADIOTHERAPY2.7095
- 850ACUTE LEUKEMIA WITH OTHER PROCEDURES8.6595
Working the claim behind this DRG
A DRG is assigned from the diagnoses and procedures already on the claim, so the questions that decide MS-DRG 830 are coding questions. Look the principal diagnosis up in the full ICD-10-CM tabular list with its Excludes1 and “code first” notes attached, or start from the condition instead of the code in the codes-by-condition index. For the secondary diagnoses that move a case between the with-MCC, with-CC and without-CC/MCC splits, paste the whole set into the free claim scrubber and see which pairs collide before the claim goes out — no account, no card.
The supplies, drugs and devices billed alongside an inpatient stay are HCPCS Level II, listed in full at HCPCS by section. If the claim comes back rejected, the denial code index explains what each CARC actually means and what to do about it, and the decision guides walk the sequencing calls that most often cause one — sepsis and diabetes above all.
Every one of those is free and needs no account. This page is the payment table: it says what MS-DRG 830 is worth. Which medical DRG a set of diagnoses lands in is the workspace’s DRG impact check, from the CMS CC/MCC lists; it does not group surgical cases.